Market revenue in 2023 | USD 3,116.2 million |
Market revenue in 2030 | USD 5,386.6 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceuticals |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 67.66% in 2023. Horizon Databook has segmented the China veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2018 to 2030.
China's veterinary medicine market is anticipated to grow over the forecast period. The factors contributing to the market growth include growing awareness among owners and increasing animal adoption.
The surge in number of pet families in the country is accompanied by the growing demand for veterinary drugs. The need for veterinary drugs has increased significantly in recent years due to the pet industry's explosive growth, making it essential for stronger R&D efforts.
In May 2022, the criteria for clinical authorization of veterinary biological products were prioritized and streamlined. The minimum requirement for the number of animals used in clinical trials to develop veterinary biological products was decreased from at least 200 animals to at least 50 animals.
Horizon Databook provides a detailed overview of country-level data and insights on the China veterinary medicine market , including forecasts for subscribers. This country databook contains high-level insights into China veterinary medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account